biospecimen__admin__batch_number	304.65.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	6
biospecimen__admin__dbgap_registration_code	000178
biospecimen__admin__disease_code	ACC
biospecimen__admin__file_uuid	B8572DB4-9B21-4C6E-93D7-C32090A0B25B
biospecimen__admin__month_of_dcc_upload	11
biospecimen__admin__program	TCGA
biospecimen__admin__year_of_dcc_upload	2018
biospecimen__bio__bcr_analyte_barcode	TCGA-OR-A5JP-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-OR-A5JP-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-OR-A5JP-01A
biospecimen__bio__biospecimen_barcode_bottom	0145632242
biospecimen__bio__day_of_creation	28
biospecimen__bio__day_of_shipment	08
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	01
biospecimen__bio__month_of_shipment	05
biospecimen__bio__pathology_report_file_name	TCGA-OR-A5JP.E7B0A3CF-35A3-433C-AF76-DB3E28DA6A46.pdf
biospecimen__bio__plate_column	3
biospecimen__bio__plate_id	A29S
biospecimen__bio__plate_row	D
biospecimen__bio__portion_sequence	1
biospecimen__bio__quantity	2.34
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	13.00
biospecimen__bio__year_of_creation	2013
biospecimen__bio__year_of_shipment	2013
biospecimen__shared__bcr_patient_barcode	TCGA-OR-A5JP
biospecimen__shared__patient_id	A5JP
clinical__acc_shared__atypical_mitotic_figures	Atypical Mitotic Figures Present
clinical__acc_shared__cytoplasm_presence_less_than_equal_25_percent	Cytoplasm presence <= 25% Present
clinical__acc_shared__diffuse_architecture	Diffuse Architecture Present
clinical__acc_shared__excess_adrenal_hormone_history_type	None
clinical__acc_shared__invasion_of_tumor_capsule	Invasion of Tumor Capsule Absent
clinical__acc_shared__mitoses_count	13
clinical__acc_shared__mitotane_therapy	YES
clinical__acc_shared__mitotane_therapy_adjuvant_setting	YES
clinical__acc_shared__mitotic_rate	Mitotic Rate > 5/50 HPF Present
clinical__acc_shared__necrosis	Necrosis Present
clinical__acc_shared__nuclear_grade_iii_iv	Nuclear Grade III or IV Present
clinical__acc_shared__sinusoid_invasion	Sinusoid Invasion Absent
clinical__acc_shared__therapeutic_mitotane_levels_achieved	YES
clinical__acc_shared__weiss_score	6
clinical__acc_shared__weiss_venous_invasion	Venous Invasion Absent
clinical__admin__batch_number	304.64.0
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	54567A50-7783-42B4-ABB7-6A2303701A1D
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__admin__year_of_dcc_upload	2016
clinical__clin_shared__age_at_initial_pathologic_diagnosis	40
clinical__clin_shared__bcr_followup_barcode	TCGA-OR-A5JP-F60579
clinical__clin_shared__bcr_followup_uuid	7EB1CE21-526A-41A7-ADFE-9E75111A5424
clinical__clin_shared__ct_scan	YES
clinical__clin_shared__ct_scan_findings	Normal
clinical__clin_shared__day_of_form_completion	11
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__laterality	Left
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__month_of_form_completion	6
clinical__clin_shared__person_neoplasm_cancer_status	TUMOR FREE
clinical__clin_shared__post_surgical_procedure_assessment_thyroid_gland_carcinoma_status	No imaging evidence of disease
clinical__clin_shared__postoperative_rx_tx	YES
clinical__clin_shared__primary_lymph_node_presentation_assessment	NO
clinical__clin_shared__primary_therapy_outcome_success	Complete Remission/Response
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Adrenal
clinical__clin_shared__year_of_form_completion	2014
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2012
clinical__nte__new_tumor_event_after_initial_treatment	NO
clinical__shared__germline_testing_performed	NO
clinical__shared__histological_type	Adrenocortical carcinoma- Usual Type
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__other_dx	No
clinical__shared_stage__clinical_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T2
gcm_curated__age	14667
gcm_curated__alt_biosample_source_id	TCGA-OR-A5JP-01A
gcm_curated__alt_donor_source_id	TCGA-OR-A5JP
gcm_curated__alt_item_source_id	TCGA-OR-A5JP-01A-11R-A29S-07
gcm_curated__assembly	GRCh38
gcm_curated__biological_replicate_count	1
gcm_curated__biological_replicate_number	1
gcm_curated__biosample_source_id	1a580a44-6d1a-4df5-8df5-f6bb0b328e68
gcm_curated__biosample_type	tissue
gcm_curated__case_source_id	0b73cbba-5520-4610-b649-912d76114033
gcm_curated__checksum	4aa6fec1f2de1b460f2a0015c770eb14
gcm_curated__data_type	Gene Expression Quantification
gcm_curated__dataset_name	GRCh38_TCGA_gene_expression_2019_10
gcm_curated__date	2019-09-12T10:51:47.000000+02:00
gcm_curated__disease	Adrenocortical Carcinoma
gcm_curated__donor_source_id	0b73cbba-5520-4610-b649-912d76114033
gcm_curated__ethnicity	white
gcm_curated__external_reference	https://portal.gdc.cancer.gov/cases/0b73cbba-5520-4610-b649-912d76114033
gcm_curated__feature	gene expression
gcm_curated__file_format	BED
gcm_curated__file_name	49e3ffbc-f75f-4f3d-99de-12c29ef69154-geq.bed
gcm_curated__gender	male
gcm_curated__is_annotation	false
gcm_curated__is_healthy	false
gcm_curated__item_source_id	49e3ffbc-f75f-4f3d-99de-12c29ef69154-geq
gcm_curated__local_url	http://www.gmql.eu/gmql-rest/datasets/public.GRCh38_TCGA_gene_expression_2019_10/49e3ffbc-f75f-4f3d-99de-12c29ef69154-geq/region
gcm_curated__pipeline	HTSeq - Counts, HTSeq - FPKM, HTSeq - FPKM-UQ
gcm_curated__project_name	TCGA-ACC
gcm_curated__replicate_source_id	1a580a44-6d1a-4df5-8df5-f6bb0b328e68
gcm_curated__size	5077151
gcm_curated__source	TCGA
gcm_curated__source_page	https://portal.gdc.cancer.gov/files/cac4369d-9154-4ef7-9f90-49042449cdf2,https://portal.gdc.cancer.gov/files/a91617da-ec4b-4fb5-9606-be0a3d9941b7,https://portal.gdc.cancer.gov/files/4eb52449-a7e5-41ce-856b-e0440e629c60
gcm_curated__source_site	University of Michigan
gcm_curated__source_url	ftp://geco.deib.polimi.it/opengdc/bed/tcga/tcga-acc/gene_expression_quantification/49e3ffbc-f75f-4f3d-99de-12c29ef69154-geq.bed
gcm_curated__species	Homo sapiens
gcm_curated__technical_replicate_count	1
gcm_curated__technical_replicate_number	1_1
gcm_curated__technique	RNA-Seq
gcm_curated__tissue	Adrenal gland
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	49e3ffbc-f75f-4f3d-99de-12c29ef69154
gdc__aliquots__concentration	0.18
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-OR-A5JP-01A-11R-A29S-07
gdc__aliquots__updated_datetime	2018-11-28T09:14:16.885469-06:00
gdc__analysis__analysis_id	15bae0a7-99d3-4971-87a5-bc59808a9df0,5f71e779-9eca-4b5c-ae7d-b59d4bd1ab39,098e209d-e61f-4bdb-a470-9ba271505c4b
gdc__analysis__workflow_link	https://github.com/NCI-GDC/htseq-cwl
gdc__analysis__workflow_type	HTSeq - FPKM,HTSeq - FPKM-UQ,HTSeq - Counts
gdc__analysis__workflow_version	v1
gdc__analytes__a260_a280_ratio	1.8
gdc__analytes__analyte_id	d0dc6b9c-884d-450e-be33-7bab2bca41c7
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__concentration	0.18
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	0b73cbba-5520-4610-b649-912d76114033
gdc__center__center_id	ee7a85b3-8177-5d60-a10c-51180eb9009c
gdc__center__center_type	CGCC
gdc__center__code	07
gdc__center__name	University of North Carolina
gdc__center__namespace	unc.edu
gdc__center__short_name	UNC
gdc__created_datetime	2016-05-26T21:10:47.274403-05:00,2016-05-26T21:10:47.106650-05:00,2016-05-26T21:10:46.910548-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	Gene Expression Quantification
gdc__demographic__age_at_index	40
gdc__demographic__days_to_birth	-14667
gdc__demographic__demographic_id	db062532-4004-530f-adfa-d196f1d87428
gdc__demographic__ethnicity	not reported
gdc__demographic__gender	male
gdc__demographic__race	white
gdc__demographic__vital_status	Alive
gdc__demographic__year_of_birth	1972
gdc__diagnoses__age_at_diagnosis	14667
gdc__diagnoses__ajcc_clinical_m	M0
gdc__diagnoses__ajcc_pathologic_n	N0
gdc__diagnoses__ajcc_pathologic_t	T2
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_diagnosis	0
gdc__diagnoses__days_to_last_follow_up	464
gdc__diagnoses__diagnosis_id	0933ed6b-ebc5-56de-a61a-b36186b32ce0
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8370/3
gdc__diagnoses__primary_diagnosis	Adrenal cortical carcinoma
gdc__diagnoses__prior_malignancy	no
gdc__diagnoses__prior_treatment	No
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Cortex of adrenal gland
gdc__diagnoses__tissue_or_organ_of_origin	Cortex of adrenal gland
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage ii
gdc__diagnoses__year_of_diagnosis	2012
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	RNA-Seq
gdc__exposures__alcohol_history	Not Reported
gdc__exposures__exposure_id	96679b58-1712-513e-9d2f-7e6adbbddec3
gdc__file_id	cac4369d-9154-4ef7-9f90-49042449cdf2,a91617da-ec4b-4fb5-9606-be0a3d9941b7,4eb52449-a7e5-41ce-856b-e0440e629c60
gdc__file_name	df34297d-30aa-484d-8d21-4c1223716469.FPKM.txt.gz,df34297d-30aa-484d-8d21-4c1223716469.FPKM-UQ.txt.gz,df34297d-30aa-484d-8d21-4c1223716469.htseq.counts.gz
gdc__file_size	498981,500296,249361
gdc__input_files__access	controlled
gdc__input_files__data_category	Sequencing Reads
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	RNA-Seq
gdc__input_files__file_id	af33883a-9b95-4946-8542-b1a01b9bb9a6
gdc__input_files__file_name	aedb5714-6162-44a7-9a19-541b5f8b7240_gdc_realn_rehead.bam
gdc__input_files__file_size	8246556170
gdc__input_files__md5sum	69431b503125cd32ada3c75d6d5a41cf
gdc__input_files__platform	Illumina
gdc__md5sum	2d59e314691dd17ae96c55a1bee2bee5,3961ef0268cedf6449ea9b86d4a08179,5bc31756e40afb6a06f93de4257cbd48
gdc__portions__is_ffpe	false
gdc__portions__portion_id	21f44722-5f0b-4924-bd4b-038d8bbf7e83
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Adrenal gland
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Adrenocortical Carcinoma
gdc__project__project_id	TCGA-ACC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	289
gdc__samples__initial_weight	60.0
gdc__samples__is_ffpe	false
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	E7B0A3CF-35A3-433C-AF76-DB3E28DA6A46
gdc__samples__sample_id	1a580a44-6d1a-4df5-8df5-f6bb0b328e68
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__samples__tissue_type	Not Reported
gdc__slides__percent_lymphocyte_infiltration	0.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	0.0
gdc__slides__percent_tumor_cells	100.0
gdc__slides__percent_tumor_nuclei	95.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	c042b97b-f12b-4f63-b32f-07247113433c
gdc__submitter_id	df34297d-30aa-484d-8d21-4c1223716469_fpkm,df34297d-30aa-484d-8d21-4c1223716469_uqfpkm,df34297d-30aa-484d-8d21-4c1223716469_count
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	OR
gdc__tissue_source_site__name	University of Michigan
gdc__tissue_source_site__tissue_source_site_id	2ff9cebf-b83f-5ec2-aae4-3aa1bf1bb02d
gdc__treatments__treatment_id	e2416703-4f5e-59e9-83e7-c12bc4b1a977
gdc__treatments__treatment_or_therapy	yes
gdc__treatments__treatment_type	Pharmaceutical Therapy, NOS,Pharmaceutical Therapy, NOS
gdc__type	gene_expression
gdc__updated_datetime	2019-09-18T14:38:42.659845+00:00
manually_curated__data_format	BED
manually_curated__download_date	2019-11-05T21:18:42.668+01:00
manually_curated__exp_data_bed_url	ftp://geco.deib.polimi.it/opengdc/bed/tcga/tcga-acc/gene_expression_quantification/49e3ffbc-f75f-4f3d-99de-12c29ef69154-geq.bed
manually_curated__exp_metadata_url	ftp://geco.deib.polimi.it/opengdc/bed/tcga/tcga-acc/gene_expression_quantification/49e3ffbc-f75f-4f3d-99de-12c29ef69154-geq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	5077152
manually_curated__local_md5	ec660c4799b081c1efc1390c2bfdb1f0
manually_curated__opengdc_download_date	2019-09-12T10:51:47.000000+02:00
manually_curated__opengdc_file_md5	4aa6fec1f2de1b460f2a0015c770eb14
manually_curated__opengdc_file_size	5077151
manually_curated__opengdc_id	49e3ffbc-f75f-4f3d-99de-12c29ef69154-geq
manually_curated__origin_file_size	5077151
manually_curated__origin_last_modified_date	Mon Sep 30 16:53:00 CEST 2019
manually_curated__origin_md5	4aa6fec1f2de1b460f2a0015c770eb14
manually_curated__tissue_status	tumoral
